| Literature DB >> 29238462 |
Zeynab Noorimotlagh1, Mahla Babaie1, Mahdi Safdarian2, Tahereh Ghadiri3, Vafa Rahimi-Movaghar4.
Abstract
OBJECTIVES: To determine the molecular and cellular mechanisms of spinal cord regeneration in zebrafish.Entities:
Keywords: Regeneration recovery-of function; Spinal cord injuries; Spinal cord regeneration; Zebrafish
Year: 2017 PMID: 29238462 PMCID: PMC5722987 DOI: 10.22038/IJBMS.2017.9620
Source DB: PubMed Journal: Iran J Basic Med Sci ISSN: 2008-3866 Impact factor: 2.699
Characteristics of studies
Abbreviations: hpl: hours post-lesion, dpl: days post-lesion, wpl: weeks post-lesion, NMLF: Nucleus of the medial longitudinal fascicle, IMRF: Intermediate reticular formation, NCAM: Neural cell adhesion molecule, MLF: Medial longitudinal fascicle, IRF: Inferior reticular formation, MON: Medial octavolateralis nucleus #the acronyms of the study methods and their frequency are shown in Table 2
| RefNo. | First author | Year | Subject | Definition of molecule or cell | Function of molecule | Site of expression | Time of study | Study methods# |
|---|---|---|---|---|---|---|---|---|
| 15 | Barreiro-Iglesias | 2015 | Serotonin | Neurotransmitter | Permissive | Midthoracic spine | 24-26, 33 hpl; 10, 14 dpl | ACX |
| 16 | Becker | 2004 | L1.1 | Recognition molecule | Permissive | Lesion site (NMLF) | 10 dpl; 6 wpl | ADIJLX |
| (Prompting regeneration) | ||||||||
| 17 | Becker | 2001 | Neuron macrophages/microglial cells | NA | NA | Axons from all descending tracts including lateral funiculus and MLF | 2, 14 dpl; 6 wpl | AEFGJL |
| 8 | Becker | 1998 | -L1.1 and L1.2 | -Recognition molecules | Permissive | NMLF, IMRF | 7, 14 dpl; 2, 3, 56, 84 dpl | ABFJX |
| -GAP-43 | -Marker of axonal growth | (Promote regeneration | ||||||
| -NCAM | -Neural cell adhesion molecule | Except to NACM) | ||||||
| -Reactive Macrophage/microglia | ||||||||
| 18 | Bormann | 1999 | zfNLRR | Neuronal-specific adhesion | Permissive | MLF and IRF in the medulla oblongata, MON, IMRF neurons and radial glial cells | 5 dpl | ABEGUX |
| molecule | (Growth promoting agent) | |||||||
| 7 | Briona | 2015 | Wnt/ß- catenin | Signaling pathway | Permissive | Blastoma and around, the level of anal pore in the spinal cord | 1, 3, 5, 7 dpl | AV |
| (Prompting regeneration) | ||||||||
| Neurogenesis, radial glia differentiation, axon regrowth. | ||||||||
| 19 | Briona | 2014 | Radial glial progenitors | NA | NA | Blastema and proximal site of injury, at the level of the anus in the spinal cord | 1, 5, 9 dpl | ABFVX |
| (Cells) | ||||||||
| 20 | Chen | 2016 | L1.2 | L1.1 paralog and ortholog of mammalian L1CAM | Permissive | Neurons and GFAP-immunoreactive glia (Islet-1, HuC/D and GFAP immunopositive cells) | 6, 11 dpl | ABCDEGHIMT |
| (functional recovery) | ||||||||
| 21 | Dias | 2012 | Notch | Notch signaling | Negative regulator of regeneration | Progenitor (radial glial progenitor) cells of specific regions of the ventricular zone and dorsal midline of spine | 14 dpl | ABDF |
| 22 | Fang | 2014 | HMGB1 | Nuclear protein | Permissive | Along the central canal and in motoneurons | 4, 12, 24 hpl; 6, 7, 11, 21 dpl | ABCDGHO |
| (amphoterin) | Or extracellular cytokine | (Prompting neurite outgrowth regeneration) | ||||||
| 23 | Goldshmit | 2012 | Lysophosphatidic Acid Signaling | inflammatory and wound-healing mediator (phospholipid) | Negative regulator | Brain and spinal cord | 3 hpl; 3, 5, 10, 21 dpl | ABCDRX |
| 24 | Goldshmit | 2012 | fgf | Growth factor | Permissive | In glial cell and injury site | 3, 5, 10 dpi; 2, 3 wpl | ABCDEGHKX |
| (Prompting regeneration) | ||||||||
| Glial cell morphogenesis | ||||||||
| 25 | Guo | 2011 | Sox11b | transcription factor | Permissive | Ependymal cells lining the central canal and in newly differentiating neuronal precursors or immature neurons | 4, 12 hpl; 11 dpl; 6 wpl | ABCDF |
| (Promotes proliferation of ependymal cells and migration of newly generated neurons) | ||||||||
| 26 | Hui | 2015 | Newly generated Cellular profile (Sox2, OCT4+/HuC/D, A 25+ cells progenitors) | NA | NA | Ependyma around the central canal | 1, 3, 7, 10; 15 dpl | ABCFKLST |
| 27 | Hui | 2010 | Cellular profile | RBC, macrophage, Schwan, neuron | NA | Injury epicenter and the adjacent part, white matter and neurons in the ependyma, subependyma at the level of dorsal fin in the spinal cord | 6 hpl; 1, 3, 5, 7, 10, 15 dpl; 4 wpl | AKLMR |
| 28 | Kuscha | 2012 | neurons | Tyrosine Hydroxylase and Serotonergic | Permissive | In the spinal cord | 1, 2, 6, 13 wpl | ABEDFQ |
| neurons | (promotes regeneration) | |||||||
| 29 | Kuscha | 2012 | Cells | interneuron cell type | NA | Around central canal of spinal cord | 2, 6 wpl | ABF |
| 30 | Lin | 2012 | Contactin-2 (TAG-1) | Cell Neural Adhesion Molecule | Permissive | NMLF, along the central canal and in motoneurons | 4, 12 hpl; 6, 11 dpl; 6 wpl | BCDEGHIO |
| (locomotor recovery and regrowth of axons) | ||||||||
| 31 | Liu | 2014 | Ptena | Tumor suppressor gene homologs of mammalian PTEN (phosphatase and tensin homolog) | Permissive | Neurons in NMLF in the brainstem, spinal motoneurons and immature neurons lining the central canal | 12 hpl; 6, 11 dpl; 4-6 wpl | ABCDEGHI |
| (locomotor recovery) | ||||||||
| 32 | Ma | 2014 | Legumain | Protease (Enzyme) | Permissive | NMLF, the caudal spinal cord | 1, 3, 11 dpl | ABCDIJN |
| (The Asparaginyl Endopeptidase) | (functional recovery) | |||||||
| 33 | Ma | 2012 | cysteine- and glycine-rich protein (CRP)1a | Growth-associated protein | Permissive | NMLF, and other nuclei such as the IMRF and superior reticular formation capable of regeneration | 3, 11-21 dpl | ABCDHIJN |
| (functional recovery) | ||||||||
| 34 | Ogai | 2014 | The sex-determining region Y-box 2 (Sox2) | Transcription factor | Permissive | Ependymal cells | 1 ,3, 5, 20 dpl | ABC |
| (proliferation initiator) | ||||||||
| 35 | Ogai | 2012 | Bcl-2 and phospho-Akt | Anti-apoptotic factors | NA | Brainstem neurons of the NMLF and IMRF | 1–15 dpl | AEFHKMP |
| 36 | Pan | 2013 | MVP (Major vault protein) | Multifunctional protein | Permissive | Ependymal cells (brainstem) | 4, 12 hpl; 6, 11 dpl; 4–6 wpl | ABCDEGHIX |
| (functional recovery and axonal regrowth) | ||||||||
| 37 | Reimer | 2009 | sonic hedgehog a (shha) | Ventral morphogen | Permissive | Ependymoradial glial cells lining the central canal in ventrodorsal positions | 1, 2, 6 wpl | ABCEP |
| (Neurogenesis) | ||||||||
| Ependymoradial glial cells | Ventricular zone | |||||||
| Transcription factors | - | |||||||
| Transcription factors | - | |||||||
| Hedgehog)hh(receptors: | Receptor | Ependymoradial glial cells including those of the pMN-like zone | ||||||
| 38 | Reimer | 2008 | olig2-positive (olig2+) | Ependymo-radial glial progenitor cells | Permissive | The ventricular zone | 1,2, 6–8 wpl | AEFKLX |
| (Motor Neuron Regeneration) | ||||||||
| 39 | Schweitzer | 2007 | Contactin1a(Cntn1a) | Homolog of contactin1 (F3/F11/ | Permissive | Brainstem neurons and white matter glial cells | 14 dpl | ABEX |
| contactin) in mammals; an immunoglobulin superfamily recognition molecule of neurons and oligodendrocytes | (oligodendrocyte | |||||||
| differentiation and axonal regeneration in the central | ||||||||
| nervous system) | ||||||||
| 40 | Schweitzer | 2003 | Protein Zero(P0) | Immunoglobulin superfamily molecule | Permissive | Spinal cord 0 to 1 mm caudal to the lesion | 14 dpl | ABUX |
| (peripheral white matter) | ||||||||
| 41 | Vajn | 2014 | Swimming distance | - | - | Reticular formation, MON, NMLF (at least four millimeters beyond the lesion) | 2, 4, 8 wpl | ADEGMP |
| 42 | Yu | 2013 | Syntenin-a | Scaffolding protein involved in mammalian cell adhesion and movement, axonal outgrowth, establishment of cell polarity, and protein trafficking | Permissive | Neurons, glia and newly generated neural cells | 4, 12 hpl; 6, 11 dpl | ABCDEGHIQ |
| (locomotor recovery and axonal regrowth-synapse formation) | ||||||||
| 43 | Yu | 2011 | miR-133b | MicroRNAs (miRNAs) | Permissive | Regenerating neurons of the brainstem, supraspinal Neurons and NMLF | 6, 24 hpl; 7 dpl; 6 wpl | BCDEFHOQ |
| (functional recovery) | ||||||||
| 12 | Yu | 2011 | Tenascin-C | Extracellular matrix glycoprotein | Permissive | Gray matter, in motoneurons | 4, 48 hpl; 11 dpl; 6 wpl | ABIDEFG |
| (locomotor recovery) | ||||||||
Frequency of study methods used to investigate outcomes
| Acronym | Study methods | Frequency of studies |
|---|---|---|
| A | Immunohistochemistry | 29 |
| B | In situ hybridization | 23 |
| C | Quantitative real-time polymerase chain reaction | 15 |
| D | Locomotor analysis (swim tracking test) | 16 |
| E | Retrograde tracing | 14 |
| F | Cell quantification (counting) | 13 |
| G | Anterograde tracing | 10 |
| H | Western blot analysis | 8 |
| I | Anti-sense Morpholino (MO) application | 7 |
| J | BrdU(5-bromo-20-deoxy-uridine)labeling assay (application) | 5 |
| K | Biocytin Application | 5 |
| L | Electron microscopy | 5 |
| M | Histology | 4 |
| N | Microarray data | 2 |
| O | Immunofluorescence analyses | 3 |
| P | Behavioral assays | 3 |
| Q | Antibody characterization | 3 |
| R | Enzyme linked immunesorbant assay (ELISA) | 2 |
| S | TUNEL staining (TdT-Mediated Deoxy-UTPNick End Labeling Assay) | 1 |
| T | Northern Blot Analysis | 2 |
| U | Confocal microscopy | 2 |
| V | Immunoblotting | 2 |
Figure 1Time course concept map
Figure 2Cellular concept map